Mysore S. Veena
- Molecular Biology top 10%
- Molecular Medicine top 0.5%
- Cancer Research top 5%
- Oncology top 10%
- Pharmacology top 5%
- Co-authors
- Eri S. SrivatsanMarilene B. WangReason WilkenAlen N. CohenSaroj K. BasakRita ChakrabartiKym F. FaullJeffrey D. Suh
- Topics
- Curcumin's Biomedical Applications (6 papers)Retinoids in leukemia and cellular processes (6 papers)Cancer, Hypoxia, and Metabolism (5 papers)
- Partner nations
- United StatesSwedenIndia
In The Last Decade
Mysore S. Veena
27 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Molecular Biology 944
- Molecular Medicine 848
- Cancer Research 327
- Oncology 308
- Pharmacology 187
Countries citing papers authored by Mysore S. Veena
This map shows the geographic impact of Mysore S. Veena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mysore S. Veena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mysore S. Veena more than expected).
Fields of papers citing papers by Mysore S. Veena
This network shows the impact of papers produced by Mysore S. Veena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mysore S. Veena. The network helps show where Mysore S. Veena may publish in the future.
Co-authorship network of co-authors of Mysore S. Veena
This figure shows the co-authorship network connecting the top 25 collaborators of Mysore S. Veena. A scholar is included among the top collaborators of Mysore S. Veena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mysore S. Veena. Mysore S. Veena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumorsbreakdown → | 20 |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 9 | |
| 6 | 22 | |
| 7 | 5 | |
| 8 | 24 | |
| 9 | 45 | |
| 10 | 3 | |
| 11 | 47 | |
| 12 | 96 | |
| 13 | 99 | |
| 14 | 61 | |
| 15 | 50 | |
| 16 | 15 | |
| 17 | 86 | |
| 18 | 29 | |
| 19 | 30 | |
| 20 | 21 |
About Mysore S. Veena
Mysore S. Veena is a scholar working on Molecular Medicine, Cancer Research and Oncology, having authored 28 papers that have together received 1.9k indexed citations. Recurring topics across this work include Curcumin's Biomedical Applications (6 papers), Retinoids in leukemia and cellular processes (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Molecular Medicine (848 citations), Cancer Research (327 citations) and Pharmaceutical Science (98 citations). Mysore S. Veena has collaborated with scholars based in United States, Sweden and India. Frequent co-authors include Eri S. Srivatsan, Marilene B. Wang, Reason Wilken, Alen N. Cohen, Saroj K. Basak, Rita Chakrabarti, Kym F. Faull, Jeffrey D. Suh, Victor M. Duarte and Daniel Sanghoon Shin. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.